Stock Market Reviews

Read and share opinions on TBPH (Theravance Biopharma, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mark

Latest News

• Theravance's Q3 Earnings Surpass Estimates, Revenues Match
  Nov 11, 2025
• Theravance Biopharma Inc (TBPH) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ...
  Nov 11, 2025
• Theravance Biopharma (TBPH) Q3 Earnings and Revenues Beat Estimates
  Nov 10, 2025
• Theravance Bio: Q3 Earnings Snapshot
  Nov 10, 2025
• Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
  Nov 10, 2025
• Theravance Biopharma to Present Data on Ampreloxetine at the 36th International Symposium on The Autonomic Nervous System
  Oct 29, 2025
• Theravance Biopharma to Report Third Quarter 2025 Financial Results on November 10, 2025
  Oct 27, 2025
• Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
  Oct 16, 2025
• Theravance Biopharma to Present New Analyses Highlighting YUPELRI® (revefenacin) Outcomes in COPD at the 2025 CHEST Annual Meeting
  Oct 14, 2025
• Theravance Bio (TBPH) Up 9.8% Since Last Earnings Report: Can It Continue?
  Sep 11, 2025
• Theravance Biopharma to Present at the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 2, 2025
• Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy
  Aug 25, 2025
• Theravance Biopharma Second Quarter 2025 Earnings: EPS Beats Expectations
  Aug 14, 2025
• Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y
  Aug 13, 2025
• Theravance Biopharma Inc (TBPH) Q2 2025 Earnings Call Highlights: Strong Sales and Strategic ...
  Aug 13, 2025
• Theravance Biopharma (TBPH) Reports Q2 Loss, Tops Revenue Estimates
  Aug 12, 2025